Publicacións en colaboración con investigadores/as de Pontifícia Universidade Católica do Rio Grande do Sul (17)

2024

  1. Factors Associated With Coronary Angiography Performed Within 6 Months of Randomization to the Conservative Strategy in the ISCHEMIA Trial

    Circulation: Cardiovascular Interventions, Vol. 17, Núm. 6, pp. 457-473

  2. Walking the talk for dementia: A unique immersive, embodied, and multi-experiential initiative

    Alzheimer's and Dementia, Vol. 20, Núm. 3, pp. 2309-2322

2023

  1. Nirsevimab binding-site conservation in respiratory syncytial virus fusion glycoprotein worldwide between 1956 and 2021: an analysis of observational study sequencing data

    The Lancet Infectious Diseases, Vol. 23, Núm. 7, pp. 856-866

2022

  1. Identifying the research, advocacy, policy and implementation needs for the prevention and management of respiratory syncytial virus lower respiratory tract infection in low- and middle-income countries

    Frontiers in Pediatrics, Vol. 10

2020

  1. Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial

    The Lancet Oncology, Vol. 21, Núm. 12, pp. 1574-1588

  2. Global molecular diversity of RSV - The "iNFORM RSV" study

    BMC Infectious Diseases, Vol. 20, Núm. 1

  3. Ibero-latinamerican clinical practical guidelines on pediatric caustic esophagitis: Physiopathology and clinical-endoscopic diagnosis (1st part)

    Revista Chilena de Pediatria, Vol. 91, Núm. 1, pp. 149-157

  4. Prevention of new respiratory episodes in children with recurrent respiratory infections: An expert consensus statement

    Microorganisms, Vol. 8, Núm. 11, pp. 1-19

2019

  1. Changing rate of serious infections in biologic-exposed rheumatoid arthritis patients. Data from South American registries BIOBADABRASIL and BIOBADASAR

    Clinical Rheumatology, Vol. 38, Núm. 8, pp. 2129-2139

2018

  1. Respiratory syncytial virus seasonality: A global overview

    Journal of Infectious Diseases, Vol. 217, Núm. 9, pp. 1356-1364

2017

  1. A Global Declaration on Appropriate Use of Antimicrobial Agents across the Surgical Pathway

    Surgical Infections, Vol. 18, Núm. 8, pp. 846-853

  2. Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results From Two Phase III Randomized, Double-Blind, Placebo-Controlled Trials

    Arthritis and Rheumatology, Vol. 69, Núm. 2, pp. 362-375

  3. The Global Alliance for Infections in Surgery: Defining a model for antimicrobial stewardship-results from an international cross-sectional survey

    World Journal of Emergency Surgery, Vol. 12, Núm. 1

  4. The burden of respiratory syncytial virus (RSV) associated acute lower respiratory infections in children with Down syndrome: A systematic review and meta-analysis

    Journal of Global Health, Vol. 7, Núm. 2

2016

  1. Meeting report: Harmonization of RSV therapeutics - from design to performance

    Journal of Global Health, Vol. 6, Núm. 1

2015

  1. Lower respiratory tract infection caused by respiratory syncytial virus: Current management and new therapeutics

    The Lancet Respiratory Medicine, Vol. 3, Núm. 11, pp. 888-900

2001

  1. Centrosome and spindle pole microtubules are main targets of a fluorescent taxoid inducing cell death

    Cell Motility and the Cytoskeleton, Vol. 49, Núm. 1, pp. 1-15